z-logo
Premium
The impact of altered annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells
Author(s) -
Hsiang ChinHui,
Tunoda Toshiyuki,
Whang Young E.,
Tyson Darren R.,
Ornstein David K.
Publication year - 2006
Publication title -
the prostate
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.295
H-Index - 123
eISSN - 1097-0045
pISSN - 0270-4137
DOI - 10.1002/pros.20457
Subject(s) - prostate cancer , annexin , lncap , signal transduction , cancer research , p38 mitogen activated protein kinases , apoptosis , kinase , annexin a5 , viability assay , mapk/erk pathway , biology , microbiology and biotechnology , cancer , medicine , biochemistry
BACKGROUND Although reduced expression levels of annexin I (ANX I) protein is a common finding in all stages of prostate cancer a causative relationship between ANX I dysregulation and prostate cancer development has yet to be established. METHODS Annexin I expression was restored in LNCaP and MDA PCa 2b that normally express low or undetectable levels of ANX I protein. The impact of restoring ANX I expression on cell viability, colony formation in soft agar, apoptosis, and extracellular signal‐regulated kinases (ERK), p38, c‐Jun N‐terminal kinases (JNK) activation was examined. RESULTS Restoring ANX I expression reduced cell viability, colony formation, in addition to inducing apoptosis. The proliferative response of epidermal growth factor was blocked by restoring ANX I expression. Furthermore, increasing basal and induced levels of phosphorylated p38 and JNK were observed in prostate cancer cells following restoration of ANX I expression. CONCLUSIONS Annexin I may have tumor suppressor functions in prostate cancer. The pro‐apoptotic effect of ANX I involves the activation of p38 and JNK, which appears to shift the balance of signal transduction away from proliferation and toward apoptosis. Prostate 66: 1413–1424, 2006. © 2006 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom